As frustrated as I am being an investor, I often have to "check myself" and think about how patients feel. Seems clear to me that all clinicians tied to the trial have known for years that the treatment flat out works. 2018 would be the latest but I truly believe its been much longer. So they have had to wait 4 years (or more) to get to this point and we still might be another 1-2 years away from regulatory approvals. All this equates to millions of GBM patients dying. If Ashkan or Liau had any say I would guess they feel we should be far further along. I fear the news of this new COVID variant will be the excuse they need to kick the can further down the road. Would not doubt that we get a PR in March, 1 year after the "in coming months" PR, where they say unforeseen delays due to COVID have shifted the timetable and they really really appreciate our patience because we are working very very very very hard.
Market Data 
Markets 
